However, likely due to the limited sample size, this improvement did not reach statistical significance when the disease cohorts were analyzed separately.
← all excerpts
Organelle-Targeted Nanotherapeutics for Parkinson's Disease: From Pathogenesis to Preclinical Strategies and Translational Challenges.
1
—
—